Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

Similar articles for PubMed (Select 21963956)

1.

Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis.

Tyler AD, Milgrom R, Xu W, Stempak JM, Steinhart AH, McLeod RS, Greenberg GR, Cohen Z, Silverberg MS.

Clin Gastroenterol Hepatol. 2012 May;10(5):507-12.e1. doi: 10.1016/j.cgh.2011.09.016. Epub 2011 Oct 1.

PMID:
21963956
2.

The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis.

Tyler AD, Milgrom R, Stempak JM, Xu W, Brumell JH, Muise AM, Sehgal R, Cohen Z, Koltun W, Shen B, Silverberg MS.

Gut. 2013 Oct;62(10):1433-9. doi: 10.1136/gutjnl-2011-301957. Epub 2012 Aug 9.

PMID:
22879519
3.

ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.

Coukos JA, Howard LA, Weinberg JM, Becker JM, Stucchi AF, Farraye FA.

Dig Dis Sci. 2012 Jun;57(6):1544-53. doi: 10.1007/s10620-012-2050-6. Epub 2012 Feb 7.

PMID:
22311367
4.

Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.

Dendrinos KG, Becker JM, Stucchi AF, Saubermann LJ, LaMorte W, Farraye FA.

J Gastrointest Surg. 2006 Jul-Aug;10(7):1060-4.

PMID:
16843878
5.

Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation.

Hui T, Landers C, Vasiliauskas E, Abreu M, Dubinsky M, Papadakis KA, Price J, Lin YC, Huiying Y, Targan S, Fleshner P.

Dis Colon Rectum. 2005 Jun;48(6):1254-62.

PMID:
15868228
6.

Utility of fecal and serum anti-Saccharomyces cerevisiae antibodies in the diagnosis of Crohn's disease-like condition of the pouch.

Tang LY, Cai H, Navaneethan U, Boone JH, Rhodes SJ, Moore L, Rho H, de La Motte C, Queener E, Shen B.

Int J Colorectal Dis. 2012 Nov;27(11):1455-63. doi: 10.1007/s00384-012-1444-4. Epub 2012 Mar 20.

PMID:
22430887
7.
8.

A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis.

White E, Melmed GY, Vasiliauskas EA, Dubinsky M, Berel D, Targan SR, Fleshner PR.

Dis Colon Rectum. 2010 Jul;53(7):987-94. doi: 10.1007/DCR.0b013e3181dcb3f2.

PMID:
20551749
9.

Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis.

Alexander F, Sarigol S, DiFiore J, Stallion A, Cotman K, Clark H, Lydzinski B, Fazio V.

J Pediatr Surg. 2003 Jan;38(1):78-82.

PMID:
12592624
10.
11.

Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis.

Fleshner P, Ippoliti A, Dubinsky M, Vasiliauskas E, Mei L, Papadakis KA, Rotter JI, Landers C, Targan S.

Clin Gastroenterol Hepatol. 2008 May;6(5):561-8. doi: 10.1016/j.cgh.2008.01.002. Epub 2008 Apr 18.

12.

Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis.

Truta B, Li DX, Mahadevan U, Fisher ER, Chen YY, Grace K, Velayos F, Terdiman JP.

Dig Dis Sci. 2014 Jan;59(1):135-45. doi: 10.1007/s10620-013-2866-8. Epub 2013 Oct 4.

PMID:
24091907
13.
14.

Antineutrophil cytoplasmic antibody subtypes in children and adolescents after ileal pouch-anal anastomosis for ulcerative colitis.

Kaditis AG, Perrault J, Sandborn WJ, Landers CJ, Zinsmeister AR, Targan SR.

J Pediatr Gastroenterol Nutr. 1998 Apr;26(4):386-92.

PMID:
9552133
15.

Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.

Werner L, Sturm A, Roggenbuck D, Yahav L, Zion T, Meirowithz E, Ofer A, Guzner-Gur H, Tulchinsky H, Dotan I.

J Crohns Colitis. 2013 Dec;7(11):e522-32. doi: 10.1016/j.crohns.2013.03.009. Epub 2013 Apr 30.

PMID:
23639628
16.

A prospective evaluation of the long-term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel disease-unclassified and indeterminate colitis.

Murrell ZA, Melmed GY, Ippoliti A, Vasiliauskas EA, Dubinsky M, Targan SR, Fleshner PR.

Dis Colon Rectum. 2009 May;52(5):872-8. doi: 10.1007/DCR.0b013e31819f5d4c.

PMID:
19502850
17.

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.

Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D.

Gut. 1998 Jun;42(6):788-91.

18.

Mucosal changes in ileal pouches after restorative proctocolectomy for ulcerative and Crohn's colitis.

Ettorre GM, Pescatori M, Panis Y, Nemeth J, Crescenzi A, Valleur P.

Dis Colon Rectum. 2000 Dec;43(12):1743-8.

PMID:
11156461
19.

A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis.

Fleshner P, Ippoliti A, Dubinsky M, Ognibene S, Vasiliauskas E, Chelly M, Mei L, Papadakis KA, Landers C, Targan S.

Clin Gastroenterol Hepatol. 2007 Aug;5(8):952-8; quiz 887. Epub 2007 Jun 4.

PMID:
17544871
20.

Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis.

Shen B, Fazio VW, Remzi FH, Brzezinski A, Bennett AE, Lopez R, Hammel JP, Achkar JP, Bevins CL, Lavery IC, Strong SA, Delaney CP, Liu W, Bambrick ML, Sherman KK, Lashner BA.

Clin Gastroenterol Hepatol. 2006 Jan;4(1):81-9; quiz 2-3.

PMID:
16431309
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk